Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Feb 08, 2023. (Total: 52533 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 411 Records)

Next

Query Trace: all[original query]>>Guidelines Related[Product Type]
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt Marjanka K et al. European journal of cancer (Oxford, England : 1990) 2023 18179-91
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
Abdel-Razeq Hikmat et al. Breast cancer (Dove Medical Press) 2023 151-10
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.
Vikas Praveen et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 JCO2202462
Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP).
Hamad Anas et al. BMC health services research 2023 23(1) 15
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Isla Dolores et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022
Updated ASCO guidelines for patients with HER2-positive breast cancer.
et al. Cancer 2022 129(1) 10
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Hulshof Emma C et al. European journal of human genetics : EJHG 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.
Hanson Helen et al. Journal of medical genetics 2022
Molecular testing for endometrial cancer: An SGO clinical practice statement.
Walsh Christine S et al. Gynecologic oncology 2022 16848-55
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Miglietta Federica et al. Breast (Edinburgh, Scotland) 2022 66293-304
Expert consensus recommendations on biomarker testing in metastatic and non-metastatic non-small cell lung cancer in Asia.
Mitsudomi Tetsuya et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.
Unterrainer Marcus et al. European journal of cancer (Oxford, England : 1990) 2022 176193-206
Multiple Endocrine Neoplasia Type 2 (MEN2) and RET Specific Modifications of the ACMG/AMP Variant Classification Guidelines and Impact on the MEN2 RET Database.
Margraf Rebecca L et al. Human mutation 2022
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy.
Aziz-Bose Rahela et al. JACC. CardioOncology 2022 4(3) 354-367
Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
Matan Liat S et al. European journal of obstetrics, gynecology, and reproductive biology 2022 278166-171
Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement.
Navani Neal et al. Lung cancer (Amsterdam, Netherlands) 2022 172142-153
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak Peter et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022 24(9) 1991
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate.
van der Pol Karel H et al. European journal of human genetics : EJHG 2022
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy.
Bartley Angela N et al. Archives of pathology & laboratory medicine 2022
Recommendations related to the analytical equivalence assessment of gene panel testing.
Nagai Sumimasa et al. Cancer science 2022
Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
R Teixeira Manuel et al. Acta medica portuguesa 2022
MEK Inhibitors for Neurofibromatosis Type 1 Manifestations: Clinical Evidence and Consensus.
de Blank Peter M K et al. Neuro-oncology 2022
International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.
Arber Daniel A et al. Blood 2022
Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer.
Rhiem Kerstin et al. Breast care (Basel, Switzerland) 2022 17(2) 199-207
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
Russo A et al. ESMO open 2022 7(3) 100459
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer.
Grafodatskaya Daria et al. Journal of medical genetics 2022
Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.
Farberg Aaron S et al. Dermatology and therapy 2022
Automated Clinical Practice Guideline Recommendations for Hereditary Cancer Risk Using Chatbots and Ontologies: System Description.
Ritchie Jordon B et al. JMIR cancer 2022 8(1) e29289
Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol [version 1; peer review: 2 approved, 2 approved with reservations].
Lewis Celine et al. NIHR open research 2022 123
Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline.
Kratz Christian Peter et al. Geburtshilfe und Frauenheilkunde 2022 82(1) 42-49
TOP